As on Wednesday, Sunshine Biopharma Inc (NASDAQ: SBFM) started slowly as it slid -1.69% to $0.86, before settling in for the price of $0.88 at the close. Taking a more long-term approach, SBFM posted a 52-week range of $0.75-$140.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 542.96%. Meanwhile, its Annual Earning per share during the time was 73.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 115.79%. This publicly-traded company’s shares outstanding now amounts to $0.99 million, simultaneously with a float of $0.95 million. The organization now has a market capitalization sitting at $0.85 million. At the time of writing, stock’s 50-day Moving Average stood at $5.6007, while the 200-day Moving Average is $25.6385.
Sunshine Biopharma Inc (SBFM) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Sunshine Biopharma Inc’s current insider ownership accounts for 4.14%, in contrast to 11.83% institutional ownership. According to the most recent insider trade that took place on Mar 04 ’24, this organization’s Chief Executive Officer bought 100,000 shares at the rate of 0.10, making the entire transaction reach 10,000 in total value, affecting insider ownership by 130,000. Preceding that transaction, on Feb 08 ’24, Company’s Chief Executive Officer bought 20,000 for 0.10, making the whole transaction’s value amount to 2,000. This particular insider is now the holder of 30,000 in total.
Sunshine Biopharma Inc (SBFM) Earnings and Revenue Records
Sunshine Biopharma Inc’s EPS increase for this current 12-month fiscal period is 115.79% and is forecasted to reach 9.99 in the upcoming year.
Sunshine Biopharma Inc (NASDAQ: SBFM) Trading Performance Indicators
Let’s observe the current performance indicators for Sunshine Biopharma Inc (SBFM). It’s Quick Ratio in the last reported quarter now stands at 3.45. The Stock has managed to achieve an average true range (ATR) of 1.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.04.
In the same vein, SBFM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -19.05, a figure that is expected to reach -8.00 in the next quarter, and analysts are predicting that it will be 9.99 at the market close of one year from today.
Technical Analysis of Sunshine Biopharma Inc (SBFM)
Through scrutinizing the latest numbers posted by the [Sunshine Biopharma Inc, SBFM], it can be observed that its last 5-days Average volume of 12.35 million was better the volume of 1.42 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 4.53% While, its Average True Range was 0.9174.
Raw Stochastic average of Sunshine Biopharma Inc (SBFM) in the period of the previous 100 days is set at 0.37%, which indicates a major fall in contrast to 1.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 329.23% that was higher than 283.45% volatility it exhibited in the past 100-days period.
